Maha Radhakrishnan

Person · Paris, France

Maha Radhakrishnan, MD, is Executive Partner at Sofinnova Investments, one of Europe's leading dedicated life science venture capital firms. A physician-scientist by training, she brings deep expertise in biopharmaceuticals and drug development to evaluating and supporting therapeutic companies across oncology, rare diseases, and CNS disorders. She is a prominent investor and speaker in the European and global biotech ecosystem.